Neurological fatigue is not ordinary tiredness that a good night’s sleep can fix. It originates in the brain itself, driven by disrupted signaling between key brain regions, neuroinflammation, and impaired cellular energy production. The result is a persistent, often overwhelming exhaustion that affects movement, thinking, and motivation in conditions ranging from multiple sclerosis to long COVID. What makes it especially frustrating for the people living with it is that standard medical tests often come back normal, and the fatigue bears little relationship to how much physical effort someone has actually exerted.
Central Fatigue Versus Peripheral Fatigue
Fatigue researchers draw a fundamental line between peripheral fatigue, which happens in the muscles themselves, and central fatigue, which happens upstream in the nervous system. Peripheral fatigue is what you feel when your legs burn after a hard run: the muscle fibers are depleted, metabolic byproducts have built up, and the tissue simply cannot contract as forcefully. Central fatigue is different. It reflects a reduced ability of the brain and spinal cord to drive the muscles in the first place.
1PubMed. Recovery of central and peripheral neuromuscular fatigue after exerciseIn healthy people, these two systems work together under what researchers call the Integrative Governor model, where the brain continuously weighs both psychological and physiological signals to regulate effort.
2PubMed Central. Central and Peripheral Fatigue in Physical Exercise Explained: A Narrative ReviewIn neurological conditions, though, the central component goes haywire. The brain’s fatigue signal fires too easily, too intensely, or fails to reset. That disconnect between actual physical capacity and perceived exhaustion is the hallmark of neurological fatigue and what makes it so disorienting for patients who look fine from the outside but feel crushed on the inside.
Dopamine and the Brain’s Motivation Circuit
One of the most developed explanations for neurological fatigue centers on dopamine, the neurotransmitter most associated with motivation and reward. The communication loop between the striatum, deep in the brain’s core, and the prefrontal cortex depends heavily on dopamine. When that loop is disrupted, the subjective experience of fatigue intensifies. Neuroimaging studies in multiple sclerosis have consistently found structural and functional abnormalities in frontal and striatal regions heavily supplied by dopamine neurons, leading researchers to propose what is called the dopamine imbalance hypothesis of fatigue.
3PubMed Central. The dopamine imbalance hypothesis of fatigue in multiple sclerosis and other neurological disordersThis is not just an MS story. Dopaminergic stimulant medications have been shown to reduce fatigue in people with traumatic brain injury, chronic fatigue syndrome, and cancer-related fatigue, suggesting that the dopamine connection cuts across diagnoses.
3PubMed Central. The dopamine imbalance hypothesis of fatigue in multiple sclerosis and other neurological disordersWork in childhood chronic fatigue syndrome has added a specific wrinkle: children with the condition showed lower activity in the putamen, a striatal structure, during low-reward situations. When the reward was high enough, their putamen activity looked more normal. The lower the putamen activity, the worse the fatigue and the less motivation children reported for everyday learning.
4PubMed Central. Low putamen activity associated with poor reward sensitivity in childhood chronic fatigue syndromeThis paints a picture where neurological fatigue is partly a failure of the brain’s reward system to generate the “worth doing” signal for ordinary activities. When the dopamine circuitry is not providing that push, even low-effort tasks can feel monumental.
Noradrenaline, a related neurotransmitter, also appears to matter. In people with MS who report high cognitive fatigue, connectivity in brain networks rich in the noradrenaline transporter is reduced, particularly in frontal and prefrontal areas. The degree of this reduction predicts how severe someone’s cognitive fatigue actually is.
5PubMed Central. Cognitive fatigue in multiple sclerosis is associated with alterations in the functional connectivity of monoamine circuitsNeuroinflammation as a Fatigue Driver
The immune system has its own route to generating fatigue, and it does not require ongoing infection. In neuro-inflammatory and autoimmune diseases, peripheral immune activation triggers a cascade: immune signals reach the brain, activate glial cells (the brain’s resident immune-like cells), and damage mitochondria. This combination of glial activation and mitochondrial harm appears to account for the severe, unrelenting fatigue seen in conditions like MS, lupus, and rheumatoid arthritis.
6PubMed Central. Central pathways causing fatigue in neuro-inflammatory and autoimmune illnessesAnimal research has clarified one specific chain of events. When the immune system is experimentally activated, microglia in the prefrontal cortex ramp up production of interleukin-1β, an inflammatory molecule. That IL-1β then boosts serotonin reuptake in nearby astrocytes, which alters serotonin availability and produces fatigue-like behavior. Blocking either the microglial activation or the IL-1β itself prevents the fatigue from developing.
7PubMed. Induction of interleukin-1β by activated microglia is a prerequisite for immunologically induced fatigueIn ME/CFS and long COVID, a similar neuroinflammatory process may sustain the illness long after the original trigger has resolved. One proposed pathway is that the initial infection or stressor creates systemic immune activation, which then crosses into the brain through neurovascular routes or a weakened blood-brain barrier, establishing chronic neuroinflammation that drives relapsing cycles of fatigue.
8PubMed Central. Molecular Mechanisms of Neuroinflammation in ME/CFS and Long COVID to Sustain Disease and Promote RelapsesWhen the Cell’s Power Plants Fail
Every cell in the body runs on ATP, and neurons are among the most energy-hungry cells we have. When mitochondria, the structures that produce ATP, are not working properly, the brain is one of the first organs to feel it. Reviews of the literature on fatigue and mitochondrial function have found a consistent picture: people with chronic fatigue show problems at multiple steps of energy production, including impaired oxidative phosphorylation, reduced activity of key enzymes in the electron transport chain, lower levels of the electron shuttle CoQ10, and disrupted ATP recycling.
9PubMed Central. Association of mitochondrial dysfunction and fatigue: A review of the literatureIn one study of chronic fatigue syndrome patients, the degree of mitochondrial dysfunction correlated strongly with how sick people were.
10PubMed Central. Chronic fatigue syndrome and mitochondrial dysfunctionAt the neural level, mitochondria are doing triple duty: generating ATP, buffering excess calcium, and managing free radicals. When any of these functions falters, neurons face an energy crisis that compromises their ability to fire and communicate normally.
11PubMed. Oxidative stress and energy crises in neuronal dysfunctionThis bioenergetic angle helps explain why neurological fatigue often worsens disproportionately after modest exertion, the phenomenon patients with ME/CFS call “post-exertional malaise.” If the cellular machinery for replenishing energy is compromised, even small demands can create outsized deficits.
Brain Network Disruptions
Fatigue is not localized to a single brain area. Imaging studies across multiple conditions point to a network-level problem, centered on connections between the thalamus, striatum, and cortex. In MS, dysfunction in this thalamo-striato-cortical network has been directly linked to fatigue severity, supporting the idea that central fatigue arises from impaired coordination between these relay and processing centers rather than damage to any one spot.
12PubMed Central. Thalamo-striato-cortical determinants to fatigue in multiple sclerosisLong COVID has given researchers another window into these circuits. PET and MRI data from long-COVID patients reveal basal ganglia disturbances including inflammation, metabolic disruption, volume changes, and altered connectivity in the striatal dopamine pathways that regulate motivation.
13PubMed Central. Decoding Post-Viral Fatigue: The Basal Ganglia’s Complex Role in Long-COVIDAfter traumatic brain injury, fatigue is thought to stem from diffuse axonal injury to the brain regions regulating arousal, attention, and processing speed, including the ascending reticular activating system, limbic areas, and basal ganglia.
14PubMed Central. Study of Fatigue and Associated Factors in Traumatic Brain Injury and Its Correlation with Insomnia and DepressionConnectivity studies of mental fatigue in otherwise healthy people reveal a broader principle: as fatigue sets in, the brain’s global integration decreases while local clustering increases. In practical terms, the brain becomes less able to coordinate across distant regions and more trapped in small, local processing loops. This shift helps explain why sustained attention tasks become progressively harder over time and why people describe a cognitive “fog” as fatigue deepens.
15Engineering. Neural Mechanisms of Mental Fatigue Revisited: New Insights from the Brain ConnectomeHow Sleep Disruption Feeds Back Into Fatigue
Poor sleep and neurological fatigue feed each other in ways that can be hard to untangle. Sleep fragmentation, even when total sleep time stays the same, alters sleep architecture by reducing both deep sleep and REM sleep. This alone is enough to increase subjective fatigue and impair cognitive performance.
16PubMed Central. Impact of Sleep Fragmentation on Cognition and FatigueThe interaction gets worse in people with brain injuries. In animal models of TBI, sleep fragmentation and brain injury each independently cause fatigue, but together their effects multiply. The combination blunts deep-sleep brain waves, further reduces REM sleep, and disrupts the normal daily rest-activity cycle far more than either insult alone. Healthy brains can compensate for lost REM sleep by catching up later, but injured brains lose that ability.
17PubMed Central. Sleep fragmentation intensifies sleep architecture disruption and fatigue after traumatic brain injuryThis matters clinically because many neurological conditions that cause fatigue also cause sleep problems. MS, Parkinson’s, TBI, and ME/CFS all carry elevated rates of insomnia, sleep apnea, or restless legs. Treating the sleep disorder does not always resolve the fatigue, but leaving it untreated virtually guarantees the fatigue will be worse.
The Autonomic Nervous System Angle
Your autonomic nervous system controls the things you do not think about: heart rate, blood pressure, digestion, temperature regulation. In ME/CFS, this system frequently malfunctions. Heart rate variability, a measure of how flexibly the autonomic system responds to changing demands, is reduced in people with ME/CFS, and this reduction predicts fatigue severity. The pattern suggests excessive sympathetic (fight-or-flight) activity that does not ease off when it should.
18PubMed Central. Reduced heart rate variability predicts fatigue severity in individuals with chronic fatigue syndrome/myalgic encephalomyelitisSystematic reviews have confirmed that people with CFS show different heart rate dynamics during tilt-table testing compared to healthy controls, with a higher prevalence of postural orthostatic tachycardia syndrome (POTS), where standing up causes an excessive heart rate spike.
19PubMed. Malfunctioning of the autonomic nervous system in patients with chronic fatigue syndrome: a systematic literature reviewThe practical consequence is that simple activities like standing in a queue or taking a shower can trigger disproportionate exhaustion, lightheadedness, and brain fog. For patients who experience this overlap, managing upright posture and fluid intake can sometimes reduce fatigue more effectively than any drug.
Sickness Behavior and Its Chronic Cousin
Everyone has experienced the fatigue that comes with a bad flu: the overwhelming urge to lie down, stop eating, withdraw from activity. This is sickness behavior, an adaptive response driven by inflammatory cytokines that conserves energy and supports immune recovery. It is a feature, not a bug. The problem arises when this response fails to switch off.
ME/CFS shares surface similarities with sickness behavior, but the underlying biology diverges in important ways. Sickness behavior is a temporary state of energy conservation aimed at fighting a pathogen. ME/CFS, by contrast, is characterized by a state of energy depletion, with activation of inflammatory, oxidative, and autoimmune pathways that persist long after any triggering infection has cleared.
20PubMed Central. A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behaviorUnderstanding this distinction matters because it pushes back against the damaging suggestion that people with chronic neurological fatigue are simply experiencing prolonged sickness behavior that they could override with willpower. The mechanisms are different, and the resolution pathways that normally end sickness behavior appear to be broken.
The Stress Hormone Connection
The hypothalamic-pituitary-adrenal (HPA) axis, the body’s central stress-response system, also plays into neurological fatigue. In chronic fatigue syndrome, research has established that HPA axis activity is reduced rather than elevated, partly due to impaired drive from the central nervous system. This matters because cortisol and related hormones normally help the body mobilize energy and maintain alertness. When the system is underactive, it becomes harder to mount the physiological response that daily activity requires.
21PubMed. Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndromePhysical and emotional stressors tend to worsen fatigue in these patients, which aligns with an HPA axis that is already operating at reduced capacity and cannot ramp up further. This also helps explain the paradox where stress management techniques sometimes help fatigue even though the fatigue is clearly biological: reducing demand on an already-depleted stress system preserves what little cortisol responsiveness remains.
Why Measuring Neurological Fatigue Remains So Difficult
One of the most persistent clinical challenges is that subjective fatigue and objective performance often do not line up. A meta-analysis examining the relationship between self-reported fatigue and objective performance measures in MS found only a small correlation between the two, with a pooled effect size of about 0.19.
22PubMed. The Relationship Between Subjective and Objective Fatigue Assessment Approaches in Multiple Sclerosis: A Meta-AnalysisIn other words, how exhausted someone says they feel only weakly predicts how they actually perform on timed cognitive or motor tasks. Similar findings have emerged in athletic monitoring, where subjective and objective fatigue measures capture complementary but largely non-overlapping information.
23PubMed Central. Relationship between Objective and Subjective Fatigue Monitoring Tests in Professional SoccerThis disconnect does not mean patients are exaggerating. It means fatigue is a multidimensional experience that questionnaires and reaction-time tests are each capturing only a slice of. Some researchers are exploring brain-based biomarkers to bridge the gap. A systematic review of resting-state EEG and MEG studies found that pathological fatigue, across multiple diagnoses, is associated with increased theta-frequency brain activity and decreased alpha-frequency activity. These patterns could eventually serve as diagnostic biomarkers, though they are not yet used clinically.
24PubMed Central. Resting-state EEG and MEG biomarkers of pathological fatigue – A transdiagnostic systematic reviewPharmacological Treatments and Their Disappointing Track Record
Given the dopamine hypothesis, stimulant-type medications would seem like logical treatments. The reality is more complicated. A rigorous randomized, double-blind trial tested three commonly used drugs for MS fatigue, amantadine, modafinil, and methylphenidate, and found that none was superior to placebo. All three caused more side effects than the placebo did.
25PubMed Central. Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trialAn earlier, smaller trial had found that modafinil at a lower dose did improve MS fatigue scores compared to placebo, but that improvement vanished at the higher dose.
26PubMed Central. Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 studyThe contrast between the two trials illustrates a broader problem in fatigue pharmacology: smaller studies often find positive signals that larger, more carefully controlled studies fail to replicate. In post-stroke recovery, a systematic review found that modafinil showed positive effects on fatigue in most of the publications examined, but the authors emphasized that higher-quality evidence is still needed.
27PubMed. Amantadine and Modafinil as Neurostimulants During Post-stroke Care: A Systematic ReviewThe takeaway is not that medication never helps individual patients, because some clearly do respond, but that blanket prescribing of stimulants for neurological fatigue is not supported by the best available evidence. The high placebo response rates in fatigue trials also suggest that expectation, attention, and the structure of clinical care play a real role in how fatigued people feel.
Non-Drug Approaches
Brain stimulation is emerging as one alternative worth watching. In a randomized, double-blind pilot study of transcranial direct current stimulation (tDCS) for post-COVID fatigue, participants who received active stimulation over the motor cortex showed significant improvements in physical fatigue compared to those who received sham treatment, and the benefit persisted at follow-up.
28Brain Communications. Transcranial direct current stimulation for post-COVID fatigue: a randomized, double-blind, controlled pilot studyThis is still a small study and far from conclusive, but it fits with the broader understanding that neurological fatigue involves dysfunctional neural circuits that might respond to targeted modulation.
Beyond tDCS, the most effective non-drug strategies tend to be indirect: pacing activity to avoid post-exertional crashes, treating co-occurring sleep disorders, managing autonomic symptoms with hydration and compression garments, and using cognitive-behavioral techniques not to “think away” the fatigue but to optimize the energy that is available. None of these are cures, but in a condition where pharmacology has largely failed to deliver, they form the practical backbone of fatigue management for most patients.
The Gut-Brain Axis as an Emerging Frontier
A newer line of research is examining whether the gut microbiome contributes to neurological fatigue. People with ME/CFS consistently show altered gut microbial composition compared to healthy controls. The microbiota-gut-brain axis, the bidirectional communication pathway between intestinal bacteria and the brain, may influence fatigue through its effects on immune responses, neurochemical signaling, and neuronal health.
29PubMed Central. The microbiota-gut-brain axis in myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review of an emerging fieldThe field is still in its early stages, and no probiotic or dietary intervention has been proven to reliably reduce neurological fatigue. But the gut-brain axis offers a plausible route by which peripheral biology could sustain central nervous system dysfunction, complementing the neuroinflammatory and bioenergetic mechanisms already described. If gut microbes are contributing to the immune activation that eventually reaches the brain, then treatments targeting the gut could, in theory, reduce neuroinflammation at its source. That remains speculative, but clinical trials testing microbiome-based interventions in ME/CFS and long COVID are underway, and results over the next few years should clarify whether this pathway is treatable or just interesting.